Astrid Lipplaa

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A pooled analysis of phase 2 clinical trials in advanced chordoma.

A pooled analysis of phase 2 clinical trials in advanced chordoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 07, 2026

Systemic Treatment of Advanced Chordoma With Molecular Targeted Therapies: A Large Multicentre European Retrospective Case Series.

Systemic Treatment of Advanced Chordoma With Molecular Targeted Therapies: A Large Multicentre European Retrospective Case Series.

Journal: Cancer reports (Hoboken, N.J.)

Published: January 31, 2026

Incidence and centralization of chordoma in the Netherlands: A nationwide study between 1991 and 2020.

Incidence and centralization of chordoma in the Netherlands: A nationwide study between 1991 and 2020.

Journal: Cancer epidemiology

Published: July 05, 2023

Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study.

Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study.

Journal: The oncologist

Published: February 26, 2023

A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor.

A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor.

Journal: Genes, chromosomes & cancer

Published: August 31, 2022

Updated concepts in treatment of giant cell tumor of bone.

Updated concepts in treatment of giant cell tumor of bone.

Journal: Current opinion in oncology

Published: July 15, 2022

RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis.

RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 22, 2022

Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial.

Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial.

Journal: The oncologist

Published: March 24, 2019

Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone.

Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone.

Journal: Current opinion in oncology

Published: March 08, 2019

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.

Journal: British journal of cancer

Published: November 30, 2017

Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series.

Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series.

Journal: Clinical sarcoma research

Published: August 13, 2016

Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

Journal: British journal of clinical pharmacology

Published: June 12, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026